Cargando…

Antitussive Use in Patients with Inadequately Controlled Moderate-to-Severe Asthma: A Post Hoc Analysis of the Omalizumab EXTRA Trial

Acute and chronic cough are common symptoms in patients with severe allergic asthma. Although asthma-related cough can be controlled by asthma-specific medications, both prescription and over-the-counter antitussives are often also necessary. The anti-immunoglobulin E monoclonal antibody omalizumab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rutland, Cedric J, Iweala, Onyinye I, Anders, Kyle, Ko, Jinnie, Mital, Parul, Gupta, Sachin, Mohan, Arjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305765/ https://www.ncbi.nlm.nih.gov/pubmed/37388705 http://dx.doi.org/10.2147/JAA.S412762

Ejemplares similares

Age of asthma onset does not impact the response to omalizumab
por: Rogers, Linda, et al.
Publicado: (2023)

Long-term effectiveness and safety of omalizumab in pediatric and adult patients with moderate-to-severe inadequately controlled allergic asthma
por: Hanania, Nicola A., et al.
Publicado: (2022)

Omalizumab treatment of moderate to severe asthma in the adolescent and pediatric population
por: O’Quinn, John, et al.
Publicado: (2014)

Antitussives and substance abuse
por: Burns, Jarrett M, et al.
Publicado: (2013)

Efficacy predictors of omalizumab in Chinese patients with moderate-to-severe allergic asthma: Findings from a post-hoc analysis of a randomised phase III study()
por: Li, Jing, et al.
Publicado: (2020)

280 Use of Omalizumab in Chronic Moderate to Severe Persistent Asthma-an Indian Experience
por: Ansari, Qamar, et al.
Publicado: (2012)

Omalizumab Effectiveness in Severe Allergic Asthma with Multiple Allergic Comorbidities: A Post-Hoc Analysis of the STELLAIR Study
por: Just, Jocelyne, et al.
Publicado: (2021)

Severe asthma and the omalizumab option
por: Miller, Christopher WT, et al.
Publicado: (2008)

Omalizumab treatment in brittle asthma
por: Skiepko, Roman, et al.
Publicado: (2014)

Omalizumab for Severe Asthma: Beyond Allergic Asthma
por: Loureiro, C. C., et al.
Publicado: (2018)

Huanglong Antitussive Granule Relieves Acute Asthma Through Regulating Pulmonary Lipid Homeostasis
por: Yan, Hua, et al.
Publicado: (2021)

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
por: Snelder, S. M., et al.
Publicado: (2017)

Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma
por: Zafari, Zafar, et al.
Publicado: (2016)

Therapeutic efficacy of omalizumab in children with moderate-to-severe allergic asthma combined with chronic sinusitis
por: Chong, Weikun, et al.
Publicado: (2023)

Omalizumab and quality of life in nasal polyps: A post hoc analysis
por: Han, Joseph K., et al.
Publicado: (2022)

Omalizumab: Clinical Use for the Management of Asthma
por: Thomson, Neil C., et al.
Publicado: (2012)

Central antitussive effect of codeine in the anesthetized rabbit
por: Simera, M, et al.
Publicado: (2010)

Comprehensive evidence-based review on European antitussives
por: Morice, Alyn, et al.
Publicado: (2016)

Successful Use of Omalizumab in an Inadequately Controlled Type 2 Diabetic Patient With Severe Insulin Allergy
por: Cavelti-Weder, Claudia, et al.
Publicado: (2012)

Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis
por: Heffler, Enrico, et al.
Publicado: (2020)

Update on optimal use of omalizumab in management of asthma
por: Pelaia, Girolamo, et al.
Publicado: (2011)

279 Near-Fatal Asthma Treated with Omalizumab
por: Contreras Contreras, Elvia Angelica, et al.
Publicado: (2012)

A review of omalizumab for the management of severe asthma
por: Lin, Ching-Hsiung, et al.
Publicado: (2016)

Omalizumab Improves Quality of Life and Asthma Control in Chinese Patients With Moderate to Severe Asthma: A Randomized Phase III Study
por: Li, Jing, et al.
Publicado: (2016)

Strategies for Mast Cell Inhibition in Food Allergy
por: Suber, Jada, et al.
Publicado: (2020)

Use of antitussive medications in acute cough in young children
por: Lam, Samuel H. F., et al.
Publicado: (2021)

Preparation of Naringenin Nanosuspension and Its Antitussive and Expectorant Effects
por: Dong, Zhengqi, et al.
Publicado: (2022)

Gender Differences in Antitussive Prescriptions for Chronic Cough in Korea
por: Park, Jinkyeong, et al.
Publicado: (2023)

Rates of asthma attacks in patients with previously inadequately controlled mild asthma treated in clinical practice with combination drug therapy: an exploratory post-hoc analysis
por: Dal Negro, Robert W, et al.
Publicado: (2009)

Neighborhoods with 25% Minority Residents Are Still Mostly White
por: Spector, Andrew R., et al.
Publicado: (2021)

The real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: The ASTERIX Observational study
por: Bhutani, Mohit, et al.
Publicado: (2017)

Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review
por: Colombo, Giorgio Lorenzo, et al.
Publicado: (2019)

Omalizumab: the evidence for its place in the treatment of allergic asthma
por: McNicholl, Diarmuid M., et al.
Publicado: (2008)

Omalizumab: clinical use for the treatment of an adolescent with difficult asthma
por: De Castro, Giovanna, et al.
Publicado: (2013)

Is Omalizumab a Problem-Solving Remedy in Severe Asthma?
por: Kim, Doh Hyung, et al.
Publicado: (2018)

Benefits of omalizumab on anxiety and depression in patients with severe asthma
por: Uzer, Fatih, et al.
Publicado: (2018)

Appropriate selection for omalizumab treatment in patients with severe asthma?
por: Nygaard, Leo, et al.
Publicado: (2017)

Omalizumab in patients with severe asthma and persistent sputum eosinophilia
por: Mukherjee, Manali, et al.
Publicado: (2019)

Omalizumab: An Optimal Choice for Patients with Severe Allergic Asthma
por: Kotoulas, Serafeim Chrysovalantis, et al.
Publicado: (2022)

Omalizumab and IgE in the Control of Severe Allergic Asthma
por: Gon, Yasuhiro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_20cc31sa72fhu8dmn7o6o55sra